Abstract: Cutaneous metastases from internal malignant neoplasms are a rare event and a late clinical finding that is associated with disseminated disease and a poor prognosis. Skin metastases from colon tumors occur in only 4% of cases of metastatic colorectal cancer. They are most often located on the abdominal skin. We report a case of 54-year-old male patient with a cutaneous metastatic focus on the lower abdomen as the initial presenting symptom of an underlying colon cancer.
INTRODUCTION
Colorectal cancer (CRC) is a globally important public health issue. More than 10% of cases are already metastatic tumors by the time they are diagnosed. The sites most often affected by the advanced disease are the liver, lungs and central nervous system. 1 Cutaneous metastases are a rare event in the evolution of these tumors, and when present, they indicate a poor prognosis, since more than two thirds of patients die within six months after diagnosis.
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CASE REPORT
A 54-year-old man complained of a tumor, located on the abdominal wall, that had grown progressively for one year and four months. The tumor was accompanied by significant 20-kg weight loss and intestinal obstipation in the last nine months. There was no previous diagnosis of neoplasia. Under dermatological examination, we observed a vegetative tumor, with friable surface and hemorrhagic and exudative foci, measuring about 6 cm in diameter, located on the lower abdomen. In the surrounding area, we noted erythema and infiltration, simulating an inflammatory process similar to cellulitis, with retraction towards the lesion (Figure 1 ).
A lesional biopsy was performed, and the histopathology showed a malignant neoplasm composed of well-formed ductal structures that had infiltrated the dermis, whose epithelium was composed of columnar cells of pleomorphic vesicular nuclei with more than one nucleolus and frequent atypical mitotic figures. The stroma 
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DISCUSSION
Cutaneous metastases of internal malignant neoplasms are rare, occurring in about 0.7% to 9% of all malignant diseases. Metastases preferentially affect cutaneous sites close to the primary tumor, which, in the case of CRC, is the abdominal wall.
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This dissemination can be explained by the direct extension of the primary tumor to the overlying skin or through dissemination by hematogenic or lymphatic means. 2 The skin is rarely affected in locations such as the pelvis, torso, thorax, upper extremities, head, neck and upper lip. [6] [7] [8] Although they resemble the primary tumors, the metastases are more anaplastic and, when located in the integument, tend to spread deeply, involving the dermis and the subcutaneous cellular tissue, without continuity with the overlying epidermis.
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The immunohistochemical study is an important complementary tool for histopathological studies. In the case of cutaneous metastases originating from CRC, the CK7-negative/CK20-positive pattern is present in more than 70% of lesions. 2 CDX2 is an expressed transcription factor in the nuclei of the epithelial cells throughout the intestine, the duodenum and the rectum. Werling RW et al. (2003) demonstrated that CDX2 was uniformly expressed in all colorectal tumors. 9 In this study, in comparison with the villin, CDX2 showed greater sensitivity and comparable specificity. The treatment of cutaneous metastases is immediately palliative, with surgical resection reserved for solitary lesions.
1,2 Radiotherapy and chemotherapy can be used for the palliation of local symptoms. Once diagnosed, the cutaneous metastases indicate a bleak prognosis: more than two thirds of patients will die within the first six months. 2 Doctors that treat patients with internal carcinomas should look for skin involvement even after a long asymptomatic period, paying special attention to all nodules, ulcers that do not heal, and persistent erythema and induration. The early detection and recognition of metastatic disease on the skin can dramatically alter the treatment and prognosis in these cases. q
